Artificial Intelligence (AI) in R&D and Clinical Trials

Watch the presentation >>  |  View the slides >>

Friday, January 29, 2021
12:00 PM - 01:30 PM Eastern Standard Time
11:00 AM - 12:30 PM Central Standard Time
09:00 AM - 10:30 AM Pacific Standard Time

In this session, FDA partners Kathleen Sanzo and Jacqueline Berman will explain how the biopharma industry is using AI to increase efficiencies during the drug development process, explore the legal and regulatory implications of AI’s application to clinical trials, and discuss the potential future of AI in the Food and Drug Administration’s drug and biologic divisions.